"At the Swedish Cancer Institute, our team works in a collaborative environment to focus on you - not your disease. We fight cancer using every available tool, from the rapidly developing science of gene sequencing to innovative treatments and therapies to the compassionate caring and support you and your loved ones deserve."

During the past decade, Swedish Cancer Institute conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 61 clinical trials were completed, i.e. on average, 51.3% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 43 clinical trials were completed. i.e. 107.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Swedish Cancer Institute" #1 sponsor was "SWOG Cancer Research Network" with 38 trials, followed by "Celgene" with 23 trials sponsored, "Swedish Medical Center" with 14 trials sponsored, "Pfizer" with 12 trials sponsored and "Radiation Therapy Oncology Group" with 12 trials sponsored. Other sponsors include 167 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Swedish Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Swedish Cancer Institute" are "Multiple Myeloma" (27 trials), "Breast Cancer" (18 trials), "Lung Cancer" (14 trials), "Lymphoma" (13 trials) and "Myelodysplastic Syndromes" (8 trials). Many other conditions were trialed in "Swedish Cancer Institute" in a lesser frequency.

Most popular intervention types in "Swedish Cancer Institute" are "Drug" (233 trials), "Biological" (40 trials), "Radiation" (30 trials), "Procedure" (18 trials) and "Other" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "radiation therapy" (15 trials), "Cyclophosphamide" (11 trials), "Rituximab" (11 trials) and "cyclophosphamide" (10 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Cancer Institute" are 232 trials for "All" genders, 32 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Swedish Cancer Institute". undefined are not yet recruiting, 41 are recruiting, 27 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 148 completed trials in Swedish Cancer Institute, 1 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Cancer Institute, 67 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".